{"id":12483,"date":"2024-10-11T20:52:32","date_gmt":"2024-10-11T18:52:32","guid":{"rendered":"https:\/\/valintermed.com\/?p=12483"},"modified":"2024-10-11T20:52:32","modified_gmt":"2024-10-11T18:52:32","slug":"okuloglandulyarnyy-sindrom-parino","status":"publish","type":"post","link":"https:\/\/valintermed.com\/en\/medlibrary\/ocular-landulyarnyy-sindrom-parino\/","title":{"rendered":"Parinaud's oculoglandular syndrome"},"content":{"rendered":"
<\/div>\n

Parinaud's oculoglandular syndrome (POS) is a disease characterized by a combination of symmetrical inflammation of the salivary and lacrimal glands, as well as enlargement of regional lymph nodes. The main cause of the syndrome is an infection associated with viruses, bacteria or parasites, which can cause qualitative changes in the ocular and visual systems, leading to visual impairment. Clinically, the syndrome can manifest itself against the background of conjunctivitis, paralysis and dysfunction of the lacrimal glands, and is often associated with systemic reactions such as fever, headache and general weakness. POS requires a comprehensive approach to diagnosis and treatment, including an assessment of all existing symptoms and their relationship with possible etiologic factors.<\/p>\n

\n
\n

Content<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n